Nanovaccine: A Breakthrough in Healthcare

Explore the groundbreaking world of nanovaccines in this physician grand rounds presentation by Dr. Balaji Narasimhan, Distinguished Professor in Engineering at Iowa State University. Delve into the growing healthcare challenges of an aging population and discover how nanovaccine technology is revolutionizing vaccine delivery methods. Learn about the importance of particle size in vaccine efficacy, and examine the development of flu vaccines and heterologous vaccines using this innovative approach. Investigate the impact of nanovaccines on B and T cell immunity, and understand their clinical performance, particularly in older adults. Explore applications in animal health and future scenarios for drug delivery, including treatments for lymphatic filariasis. Gain insights into the Nanovaccine Institute's systems approach and its role in the Iowa ecosystem, including its potential impact on cardiology. Uncover the potential of nanovaccines to transform healthcare delivery and improve patient outcomes across various medical fields.

Introduction
Welcome
Disclaimer
Healthcare is growing
Aging population
Size
Materials
Spray Drying
Delivery Methods
Safety
Particle Size
Why Particle Size Matters
Summary of Work
Flu Vaccine
Heterologous Vaccine
B T Cell Immunity
Vaccine Design
Nanovaccine Efficacy
Nanovaccine Clinical Performance
Nanovaccine in Older Adults
Nanovaccine in Devices
Animal Health
Future Scenarios
Drug Delivery
Lymphatic filariasis
Conclusion
Nanovaccine Institute
Systems Approach
Ecosystem
State of Iowa
Iowa State Research Park
Role in cardiology